17th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment
The Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment, NCHIV, is a scientifically focused meeting. The aim of the conference is to review and share knowledge on the current status and new developments in understanding HIV pathogenesis, vaccine research and treatment. In addition, the conference aims to be a discussion platform for changes in the HIV epidemic in the Netherlands and to provide input for HIV public health and health care policy issues from a research perspective.Prijzen
Beroepen
Competenties
NCHIV serves as platform for stakeholders in the Netherlands to share and discuss the latest insights and developments in research concerning the pathogenesis, epidemiology, prevention and treatment of HIV.
The annual program hosted in English, includes invited lectures, presentations of original research and sessions which link research to societal impact and policy development by a faculty of national and international speakers.
Who is it for?
NCHIV is intended for a wide audience, including biomedical scientists in HIV/AIDS, HIV treating physicians, pharmacologists, infectious disease epidemiologists, (medical) microbiologists and HIV nurses.
Conference programme NCHIV 2024
We are pleased to announce part of our confirmed conference program:
- Geriatric Syndromes: Increasing Awareness of Factors Affecting Health-span of Aging PLWH
Prof. Julian Falutz (McGill University Health Centre, Montreal, Canada)
- Doxycycline post-exposure prophylaxis: are we ready to implement?
To include a multi-stakeholder panel (panelists TBA) discussion moderated by Prof. Henry de Vries (GGD Amsterdam & Amsterdam UMC) and Dr. Sacha de Stoppelaar (LCI/RIVM)
- “Spiralling towards an HIV Cure”
To include selected oral abstracts, an invited plenary by Prof. Thumbi Ndung’u (University of KwaZulu-Natal, South Africa) and contributions from SPIRAL consortium investigators of interdisciplinary research themes & challenges relevant to conducting HIV cure research in Sub-Saharan Africa